Concepedia

Nishanth Belugali Nataraj

NB

Statistics

Publications

21

Citations

921

H-Index

16

Active since

2012

Affiliations

Weizmann Institute of Science(Current)

Heidelberg University

German Cancer Research Center

Tel Aviv University

Sheba Medical Center

Nishanth Belugali Nataraj is an author at Weizmann Institute of Science specializing in molecular oncology, oncology, and medicine.

Publications per year

2012–2023

21

Publications

21

<i>TP53</i> missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment

Martino Maddalena, Giuseppe Mallel, Nishanth Belugali Nataraj et al. · Proceedings of the National Academy of Sciences · 2021 · 113 citations · Full text

Medicine, Cancer Biology, Oncology +17

Altered p53 functionality in cancer-associated fibroblasts contributes to their cancer-supporting features

Sharathchandra Arandkar, Noa Furth, Yair Elisha et al. · Proceedings of the National Academy of Sciences · 2018 · 110 citations · Full text

Medicine, Cancer Biology, Oncology +15

Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients

Ori Hassin, Nishanth Belugali Nataraj, Michal Shreberk‐Shaked et al. · Nature Communications · 2022 · 107 citations · Full text

Medicine, Molecular Genetics, Oncology +17

AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer

Ashish Noronha, Nishanth Belugali Nataraj, Joo Sang Lee et al. · Cancer Discovery · 2022 · 103 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Proteomic patterns associated with response to breast cancer neoadjuvant treatment

Anjana Shenoy, Nishanth Belugali Nataraj, Gili Perry et al. · Molecular Systems Biology · 2020 · 68 citations · Full text

Medicine, Molecular Biology, Oncology +17

1–5 of 21